Deutsche Bank Aktiengesellschaft Begins Coverage on Stevanato Group (NYSE:STVN)

Analysts at Deutsche Bank Aktiengesellschaft initiated coverage on shares of Stevanato Group (NYSE:STVN) in a research note issued on Wednesday, MarketBeat.com reports. The firm set a “hold” rating on the stock.

A number of other analysts also recently issued reports on the stock. TD Cowen upgraded shares of Stevanato Group to a “strong-buy” rating in a report on Wednesday, June 17th. UBS Group initiated coverage on Stevanato Group in a report on Wednesday, September 9th. They issued a “neutral” rating and a $23.00 price objective on the stock. Finally, Weiss Ratings upgraded Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, August 27th. Two analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Stevanato Group Trading Up 0.5%

Shares of STVN stock opened at €19.30 on Wednesday. The company’s 50-day moving average price is €21.07 and its 200-day moving average price is €18.61. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.21. The stock has a market cap of $5.85 billion, a price-to-earnings ratio of 34.47, a PEG ratio of 1.59 and a beta of 0.78. Stevanato Group has a twelve month low of €12.89 and a twelve month high of €27.99.

Stevanato Group (NYSE:STVN) last released its quarterly earnings data on Wednesday, August 5th. The company reported €0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of €0.15 by (€0.01). Stevanato Group had a return on equity of 10.43% and a net margin of 10.99%.The firm had revenue of €302.00 million for the quarter. As a group, equities analysts predict that Stevanato Group will post 0.69 earnings per share for the current year.

Insider Transactions at Stevanato Group

In other Stevanato Group news, Director Elisabetta Magistretti sold 2,045 shares of the business’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of €20.09, for a total value of €41,084.05. Following the completion of the transaction, the director owned 2,930 shares in the company, valued at €58,863.70. The trade was a 41.11% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Luciano Santel sold 2,023 shares of the company’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of €20.09, for a total value of €40,642.07. Following the sale, the director directly owned 4,739 shares in the company, valued at €95,206.51. This represents a 29.92% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 21,926 shares of company stock worth $459,738 over the last quarter. 0.70% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of STVN. Fenimore Asset Management Inc purchased a new stake in Stevanato Group during the 3rd quarter worth about $12,212,000. Integrated Wealth Concepts LLC purchased a new position in shares of Stevanato Group in the 2nd quarter valued at about $59,000. Squarepoint Ops LLC boosted its stake in shares of Stevanato Group by 131.2% in the 2nd quarter. Squarepoint Ops LLC now owns 193,311 shares of the company’s stock valued at $3,493,000 after buying an additional 109,702 shares during the period. Wellington Management Group LLP acquired a new position in shares of Stevanato Group during the second quarter worth about $22,621,000. Finally, Ranger Investment Management L.P. acquired a new position in shares of Stevanato Group during the second quarter worth about $21,438,000.

About Stevanato Group

Stevanato Group S.p.A. is an Italy-based provider of drug-containment, drug-delivery and diagnostic solutions for the pharmaceutical, biotechnology and healthcare industries. The company serves customers across the development, production and administration of injectable medicines, with activities spanning pharmaceutical glass packaging, medical devices and manufacturing technologies.

Its product portfolio includes glass vials, cartridges, syringes and other primary containers, as well as ready-to-use packaging solutions such as EZ-fill.